CANCvsSBIOETF Comparison
Tema Oncology ETF (CANC) and ALPS Medical Breakthroughs ETF (SBIO) belong to the same industry segment: Tomorrow's Treatments. CANC's top 3 sector exposures are and Health Care. CANC is more expensive with a Total Expense Ratio (TER) of 0.99%, versus 0.5% for SBIO. CANC is up 10.62% year-to-date (YTD) with +$50M in YTD flows. SBIO performs worse with 6.34% YTD performance, and +$19M in YTD flows. Run a side-by-side ETF comparison of CANC and SBIO below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
CANC vs SBIO performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | CANC SBIO | +10.08%+12.66% | +5.34%+3.68% | +10.62%+6.34% | +55.67%+90.50% | n/a+86.93% | n/a+11.39% |
| Flows | CANC SBIO | +$5M+$13M | +$29M+$16M | +$50M+$19M | +$70M+$13M | --$5M | --$60M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | CANC SBIO | +23.62%+33.23% | +23.46%+29.78% | n/a+29.96% | n/a+33.52% |
| Max drawdown | CANC SBIO | -7.99%-9.27% | -10.53%-11.04% | n/a-42.12% | n/a-53.58% |
| Max drawdown duration | CANC SBIO | 43d64d | 32d75d | n/a331d | n/a1672d |
CANC | SBIO | |
Last sale 4/27/2026 at 1:30 PM | $37.78 | $54.26 |
| Previous close 04/24/2026 | $38.36 | $54.41 |
| Consolidated volume 04/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
CANC | SBIO | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
CANC | SBIO | |
|---|---|---|
| Last price | $37.78 | $54.26 |
| 1D performance | -1.52% | -0.28% |
| AuM | $179.70 M | $153.60 M |
| E/R | 0.99% | 0.5% |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
